[Preliminary clinical study on an antitremorine derivative: 1'(2-oxo 1-pyrrolidino)-1(1-perhydroazepino)4,2 butyne].
D001381:Azepines / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D011759:Pyrrolidines / Q000627:therapeutic use*
D001381:Azepines; D011759:Pyrrolidines
Etude clinique préliminaire d'un dérivé antitrémorine: 1'(oxo-2 pyrrolidino-1)-1 (perhydroazepino-1) 4 butyne 2.